Browsing by Subject "Darolutamida"

Now showing items 1-1 of 1

Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage

Ibáñez, Cristina; Tourís Lores, Manuel; Montesa, Alvaro; Lopez Campos, Fernando; RIOS GONZALEZ, EMILIO; Usán, Paola; Moretones, Cristina; Conde-Estévez, David (Expert Opinion on Drug Metabolism & Toxicology, 2025, 19 març, 2025-03)

Introduction New androgen receptor pathway inhibitors (ARPIs) are an essential part of the treatment strategy for patients with metastatic hormone-sensitive prostate cancer (mHSPC). Despite the good ...